Clinical trials
Phase 4 Intermittent Claudication trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 5 |
| Terminated | 4 |
| Withdrawn | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Flanders Medical Research Program | 3 |
| Aalborg University Hospital | 1 |
| Arkansas Heart Hospital | 1 |
| AstraZeneca | 1 |
| Baker Heart and Diabetes Institute | 1 |
| Baylor College of Medicine | 1 |
| Biotronik AG | 1 |
| Colorado Prevention Center | 1 |
| Hospital Universitario Getafe | 1 |
| Hull University Teaching Hospitals NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Intermittent Claudication | 28 |
| Peripheral Arterial Disease | 14 |
| Peripheral Vascular Diseases | 9 |
| Chronic Limb-Threatening Ischemia | 5 |
| Atherosclerosis | 4 |
| Arterial Occlusive Diseases | 3 |
| Vascular Diseases | 3 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hypercholesterolemia | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.